Jenoptik Q3 Earnings Call Highlights

Key Points

• Jenoptik raised its 2026 EBITDA margin outlook to around 22%, while keeping its revenue growth forecast at 5%–9%. Nine-month revenue rose nearly 7%, and EBITDA increased more than 35% to about €178 million.
• Semiconductor demand drove strong orders and profitability: group order intake climbed more than 40%, backlog topped €900 million, and Semi & Advanced Manufacturing revenue grew nearly 17%. Management cautioned that Q3’s margin above 26% reflected an unusually favorable product mix and should not be assumed to continue.
• Other businesses showed mixed results: Biophotonics orders grew, Smart Mobility revenue rose nearly 12%, while automotive weakness weighed on Metrology & Production Solutions. Free cash flow improved and leverage fell to 1.1 times from 1.6 times at year-end 2025.

Jenoptik ETR: JEN reported accelerating revenue growth and stronger profitability in the first nine months of 2026, as semiconductor demand lifted orders and an unusually favorable product mix boosted third-quarter margins.

The company reiterated its full-year revenue growth forecast of 5% to 9% and raised its expected EBITDA margin to around 22%, from a previous range of 20% to 21%. Chief Executive Dominic Dorfner said the revised profit outlook reflected the improved product mix during the first three quarters.

Revenue rose almost 7% in the nine-month period, including approximately 18% growth in the third quarter, Chief Financial Officer Prisca Havranek-Kosicek said. Group EBITDA increased more than 35% to around €178 million, while earnings per share climbed 60% to €1.28.

Semiconductor Demand Drives Orders and Margins

Dorfner said order intake in Jenoptik’s original equipment manufacturer businesses exceeded expectations, led by semiconductor-related demand. Group order intake rose more than 40% year over year, and the nine-month book-to-bill ratio reached approximately 1.4 times. The order backlog grew to more than €900 million.

In Semi & Advanced Manufacturing, demand was driven by lithography and semiconductor inspection customers. Nine-month revenue in the unit grew almost 17%, while its EBITDA margin reached nearly 34%.

Havranek-Kosicek said the group’s third-quarter EBITDA margin exceeded 26%, helped by revenue growth, lower costs following a reduction program last year and an exceptionally strong product mix, particularly in the semiconductor business. She cautioned investors not to extrapolate the third-quarter margin into future periods.

“In Q3, literally everything was going right, and things were firing on all cylinders,” Havranek-Kosicek said. She added that personnel costs had lagged the production ramp as the company worked to add staff, and that the gradual ramp-up of the Dresden factory should support semiconductor margins going forward.

Despite the margin warning, the CFO said Jenoptik expected semiconductor revenue in coming quarters to remain broadly in line with the higher third-quarter level. She also noted that the fourth quarter typically has fewer production days.

Backlog Supports Outlook

Dorfner said Jenoptik expected 30% to 35% of its order book to translate into sales during 2026, with the vast majority of the remainder becoming revenue in 2027. He said customer discussions indicated no sudden change in demand, although quarterly orders could remain volatile.

The CEO also said visibility had improved compared with both last year and the first half of 2026. He described demand from major semiconductor equipment customers in lithography and inspection as strong for 2027 and beyond, with no signals of a change in 2027 or 2028.

Jenoptik is expanding high-precision clean-room production at its Jena site, principally for semiconductor inspection. Dorfner said the company was targeting the end of 2027 to bring the expanded production online. He said capacity expansion was not expected to be a hurdle to growth next year, although the company remained focused on equipment, staffing and its supply chain.

The company expects capital expenditure in 2026 to be lower than in 2025, revising its earlier expectation of only a slight decline. Dorfner attributed the change mainly to smaller items shifting into next year and said it was too early to provide a 2027 capital spending forecast.

Mixed Performance Across Other Businesses

Biophotonics order intake increased around 11% year over year despite a strong comparison period, with medtech and life sciences driving growth. Revenue in the unit was slightly below the prior-year level, partly reflecting a strong dental business last year, though defense largely offset the decline. Havranek-Kosicek said the unit remained on course for moderate full-year growth.

Dorfner said the business continued to benefit from demand for defense products, including infrared cameras and laser rangefinders. He cautioned that orders could be volatile because of defense ordering patterns and the unit’s concentrated key-account model.

Metrology & Production Solutions returned to profitability for the nine-month period, but automotive markets remained difficult, particularly in Europe. Jenoptik took an impairment charge related to its Hommel business after revising its medium-term plans. Smart Mobility Solutions revenue rose almost 12%, supported by growth across most regions.

Havranek-Kosicek said the company still intended to divest its Prodomax business but could not provide a timeline. She described its third-quarter operational performance as cautiously positive, while noting that North American automotive conditions and sentiment between Canada and the United States had not improved markedly.

Cash Flow and Capital Allocation

Free cash flow increased year over year, helped by lower investment outflows than in the prior-year period, which included substantial spending on a new factory. The working capital ratio stood at around 31%, and leverage declined to 1.1 times from 1.6 times at the end of 2025.

Dorfner said Jenoptik’s capital allocation priorities remained organic growth, stable dividends and potential bolt-on acquisitions. The company plans to provide further details on its strategy at a Capital Markets Day in Dresden on December 3.

About Jenoptik (ETR:JEN)

Jenoptik AG provides advanced photonic solutions and smart mobility solutions in Germany and internationally. The company provides imaging solutions and cameras, including microscope and thermographic camera, imaging modules, polymer-based camera modules, and miniaturized digital microscope subsystem; and laser and laser technology, such as laser ablation, scoring, cutting, and rangefinder, as well as laser OEM solutions comprising diode laser and disk laser technology, diode pumped disk lasers, laser systems, and LK heat sink.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.